Ad Banner Web

Synopsis: Inventurus Knowledge Solutions, Aqylon Nexus, Delta Corp, Marsons, and Panacea Biotec came into focus after notable bulk and block deals on June 5, 2026, indicating significant investor activity and ownership changes.

Several stocks attracted investor attention after significant bulk and block deals were reported on the exchanges. These transactions, involving large volumes of shares traded between institutional investors and other major market participants, are closely monitored by the market as they can provide insights into changing ownership trends, investor interest, and overall market sentiment toward the companies. Here are a few Bulk and Block deals that took place on June 5, 2026

Inventurus Knowledge Solutions Limited

With a market capitalization of Rs. 29,073.07 crore, the shares of Inventurus Knowledge Solutions Limited were currently trading at Rs. 1,694.50 per equity share, rising nearly 0.37 percent from its previous day’s close price of Rs. 1,688.25.

Kedaara Capital Public Markets Fund I purchased an additional 2 lakh shares, representing a 0.11 percent stake, in Inventurus Knowledge Solutions Limited from Scott Hayworth through a block deal on June 4, 2026. The transaction was executed at Rs. 1,654.90 per share, with a total deal value of approximately Rs. 33.09 crore.

delta exchange

This follows another transaction in the previous trading session, where the same parties exchanged 1.55 lakh shares of the company. The consecutive stake purchases indicate continued investor interest in Inventurus Knowledge Solutions, a healthcare solutions provider, through large-market block transactions.

Inventurus Knowledge Solutions Limited (often branded as IKS Health) is an Indian healthcare technology and services company that runs a tech-enabled “care enablement” platform for provider organizations, mainly in the US, Canada and Australia. It focuses on taking over clinical and administrative workloads so physicians and hospitals can concentrate on patient care.

tradebrains portal smallcase

Aqylon Nexus Limited

With a market capitalization of Rs. 1,490.16 crore, the shares of Aqylon Nexus Limited were currently trading at Rs. 58.73 per equity share, down nearly 1.18 percent from its previous day’s closing price of Rs. 59.43.

Kurjibhai Premjibhai Rupareliya sold 37.58 lakh shares of Aqylon Nexus Limited through a bulk transaction on June 4, 2026. The deal was executed at an average price of Rs. 56.18 per share, taking the total transaction value to approximately Rs. 21.11 crore. 

Aqylon Nexus Limited is an Indian public technology and business solutions company listed on Indian stock exchanges. It focuses on frontier technologies spanning artificial intelligence, space systems, semiconductor design, datacenter infrastructure, and smart agriculture, evolving from its earlier identity as a media broadcaster.

zerodha banner

Delta Corp Limited

With a market capitalization of Rs. 1,793.80 crore, the shares of Delta Corp Limited were currently trading at Rs. 66.99 per equity share, rising nearly 1.35 percent from its previous day’s closing price of Rs. 66.10.

L7 Securities Private Limited sold 21.46 lakh shares of Delta Corp Limited through a bulk transaction on June 4, 2026. The deal was executed at an average price of Rs. 66.81 per share, taking the total transaction value to approximately Rs. 14.33 crore.

Delta Corp Limited is an Indian public company headquartered in Mumbai, Maharashtra, operating primarily in casino gaming and hospitality. Incorporated in 1990, it is India’s only listed gaming and hospitality enterprise, with a vertically integrated model spanning offshore casinos, hotels, and real estate. Its businesses are concentrated in Goa, Sikkim, and Daman, catering to the country’s regulated entertainment and tourism markets.

Marsons Limited

With a market capitalization of Rs. 2,294.95 crore, the shares of Marsons Limited were currently trading at Rs. 133.35 per equity share, rising nearly 0.98 percent from its previous day’s closing price of Rs. 132.05.

MKJ Enterprises Ltd. purchased 10 lakh shares of Marsons Limited through a bulk transaction on June 4, 2026. The deal was executed at an average price of Rs. 133.02 per share, taking the total transaction value to approximately Rs. 13.30 crore.

Marsons Limited is an Indian manufacturer of power and electrical equipment, best known for producing transformers and related systems for utility and industrial applications. Established in the early 1970s, it operates primarily in the power transmission and distribution sector, serving both domestic and international markets.

Panacea Biotec Limited

With a market capitalization of Rs. 3,386.86 crores, the share of Panacea Biotec Limited has reached an intraday high of Rs. 577.95 per equity share, rising nearly 11.04 percent from its previous day’s close price of Rs. 520.50. Since then, the stock has retreated and is currently trading at Rs. 552.95 per equity share.

OHM Investment Corporation purchased 3.15 lakh shares of Panacea Biotec Limited through a bulk transaction on June 4, 2026. The deal was executed at an average price of Rs. 493.07 per share, taking the total transaction value to approximately Rs. 15.53 crore.

Panacea Biotec Limited is an Indian pharmaceutical and biotechnology company engaged in the research, development, manufacturing, and marketing of vaccines and pharmaceutical formulations. Headquartered in New Delhi, it is known for its contributions to immunization programs and for developing affordable vaccines for both domestic and global markets.

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.

  • : Author

    Nikhil is a Financial Analyst with over 1.5 years of experience at Trade Brains and a total of 5 years of experience in the financial markets, holding an MBA in Finance and having cleared CA-CPT and CA-Intermediate. Brings strong expertise in equity research, IPO analysis, and financial statement evaluation, with a track record of authoring more than 1,500 in-depth, research-focused articles.

× Ad Banner desktop Advertisement